RECIST criteria is not always reported accurately, and variability in tumor response assessment may be disastrous for measuring true treatment effect. Here’s how your CRO can support more consistent RECIST reads.
Breast Cancer Clinical Trials: A Caregiver, Advocate, and Project Manager’s Perspective “Being an advocate for my mother made a big difference,” Tamara said. “Some people might be going through this process alone, or may not be able to understand the whole disease. I feel I was fortunate to be able to put my oncology background...
Researchers have found a possible explanation for why many cancer drugs work in mouse models but not human, along with a new method for starving cells, and an unexpected discovery regarding transposons & blood cancers. Explore this months oncology round-up:
February 4th marks World Cancer Day, led by the Union for International Cancer Control (UICC). As a CRO with expertise in oncology, PharPoint Research is dedicated to uniting in the fight against cancer.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.